WO2023182241A1 - Composition pour matériau dentaire et matériau dentaire - Google Patents

Composition pour matériau dentaire et matériau dentaire Download PDF

Info

Publication number
WO2023182241A1
WO2023182241A1 PCT/JP2023/010757 JP2023010757W WO2023182241A1 WO 2023182241 A1 WO2023182241 A1 WO 2023182241A1 JP 2023010757 W JP2023010757 W JP 2023010757W WO 2023182241 A1 WO2023182241 A1 WO 2023182241A1
Authority
WO
WIPO (PCT)
Prior art keywords
meth
inorganic particles
mass
dental
dental material
Prior art date
Application number
PCT/JP2023/010757
Other languages
English (en)
Japanese (ja)
Inventor
直志 柿沼
絵梨 安保
洋子 小杉
Original Assignee
三井化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 三井化学株式会社 filed Critical 三井化学株式会社
Publication of WO2023182241A1 publication Critical patent/WO2023182241A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/62—Photochemical radical initiators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/70—Preparations for dentistry comprising inorganic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/70—Preparations for dentistry comprising inorganic additives
    • A61K6/71—Fillers
    • A61K6/77—Glass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/84—Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/84—Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
    • A61K6/844—Noble metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/869—Zeolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Definitions

  • the present disclosure relates to compositions for dental materials and dental materials.
  • a dental material composition such as a composite resin generally contains a dental material composition containing a monomer, a filler, a polymerization initiator, a polymerization inhibitor, a pigment, and the like.
  • a radically polymerizable polyfunctional methacrylate composition is sometimes used from the viewpoints of in-vivo safety of the monomer and mechanical strength and abrasion resistance of the cured product.
  • Patent Document 1 describes an amine compound (A) having two or more amino groups, an iso(thio)cyanate compound (B) having two or more iso(thio)cyanate groups, and one polymerizable group.
  • a (meth)acrylate (D) which is a reaction product of the above-mentioned hydroxy (meth)acrylate compound (C) is described.
  • a wide variety of bacteria reside in the oral cavity, and these bacteria form dental plaque starting from sugar, leftover food, etc., and eventually form a biofilm. Biofilm formation can be suppressed by antibacterial agents, antifouling coats, etc.
  • antibacterial agents have problems such as biological safety and initial digestion
  • antifouling coats have problems such as complicated processing and easy peeling.
  • compositions for dental materials containing a monomer and simple silver as an antibacterial component.
  • an antibacterial component there is room for improvement in antibacterial properties of dental material compositions containing silver alone.
  • sulfur components that cause bad breath exist in the oral cavity, and when a dental material composition containing silver ions is used in the oral cavity, this composition, a dental material containing a cured product of the composition, There is a problem in that the material tends to turn black over time.
  • the present disclosure has been made in view of the above, and provides a dental material composition that has excellent antibacterial properties and suppresses discoloration due to sulfur components, and a dental material containing a cured product of this dental material composition. With the goal.
  • a composition for dental materials comprising inorganic particles carrying at least one metal component selected from the group consisting of silver and zinc, a (meth)acrylate compound, and a polymerization initiator.
  • the inorganic particles contain one or more compounds selected from the group consisting of aluminosilicate and phosphate glass.
  • the content of the inorganic particles is 0.01% by mass to 15% by mass with respect to the total amount of the composition for dental materials. .
  • the content of the inorganic particles according to any one of ⁇ 1> to ⁇ 3> is 0.01 parts by mass to 40 parts by mass based on 100 parts by mass of the (meth)acrylate compound.
  • Composition for dental materials ⁇ 5>
  • the composition further contains a filler other than the inorganic particles, and the content of the filler other than the inorganic particles is 50% by mass or less based on the total content of fillers contained in the dental material composition.
  • the dental material composition according to any one of ⁇ 1> to ⁇ 4> which does not contain fillers other than the inorganic particles.
  • a dental material comprising a cured product of the dental material composition according to any one of ⁇ 1> to ⁇ 7>.
  • a dental material composition that has excellent antibacterial properties and suppresses discoloration due to sulfur components, and a dental material containing a cured product of this dental material composition.
  • numerical ranges indicated using “ ⁇ ” include the numerical values written before and after " ⁇ " as minimum and maximum values, respectively.
  • the upper limit or lower limit described in one numerical range may be replaced with the upper limit or lower limit of another numerical range described step by step.
  • the upper limit or lower limit of the numerical range may be replaced with the values shown in the Examples.
  • “(meth)acryloyl” means acryloyl or methacryloyl
  • “(meth)acrylate” means acrylate or methacrylate.
  • the dental material composition refers to a composition in which the dental material composition itself, a cured product of the dental material composition, or a product obtained by further processing the cured product can be used as a dental material. means.
  • the amount of each component in a composition if there are multiple substances corresponding to each component in the composition, unless otherwise specified, the amount of each component in the composition is means the total amount.
  • the specific inorganic particles may be read as silver-supported zeolite, zinc-supported zeolite, silver-zinc-supported zeolite, silver-supported zirconium compound, zinc-supported zirconium compound, or silver-zinc-supported zirconium compound.
  • the dental material composition of the present disclosure comprises inorganic particles (hereinafter also referred to as "specific inorganic particles") on which at least one metal component selected from the group consisting of silver and zinc is supported, and (meth)acrylate It contains a compound and a polymerization initiator.
  • specific inorganic particles on which at least one metal component selected from the group consisting of silver and zinc is supported, and (meth)acrylate It contains a compound and a polymerization initiator.
  • the dental material composition of the present disclosure includes at least one of silver-supported inorganic particles, zinc-supported inorganic particles, and silver and zinc-supported inorganic particles as specific inorganic particles. include. This provides excellent antibacterial properties and suppresses discoloration due to sulfur components. More preferably, by using specific inorganic particles, the antibacterial effect can be easily maintained for a long period of time and discoloration such as blackening can be suppressed compared to the case where silver alone is used.
  • Metals such as silver alone and zinc exhibit excellent antibacterial properties, but when used in dental materials such as dental composite resins, adhesives, and cement materials, they may cause color changes during product storage or after product use. is remarkable.
  • dental materials such as dental composite resins, adhesives, and cement materials
  • the antibacterial compounds tend to react with acidic group-containing monomers such as acidic (meth)acrylate compounds, reducing their hardenability.
  • acidic group-containing monomers such as acidic (meth)acrylate compounds
  • the dental material composition of the present disclosure includes inorganic particles (specific inorganic particles) on which at least one metal component selected from the group consisting of silver and zinc is supported.
  • the specific inorganic particles are not particularly limited as long as they support at least one of silver and zinc.
  • the specific inorganic particles may be inorganic particles on which only silver is supported, may be inorganic particles on which only zinc is supported, or may be inorganic particles on which only silver and zinc are supported,
  • the inorganic particles may support at least one of silver and zinc and a component other than silver and zinc.
  • One type of specific inorganic particles may be used alone, or two or more types may be used in combination.
  • the inorganic particles on which at least one of silver and zinc is supported preferably have a porous structure from the viewpoint of supporting ability of metal components.
  • the inorganic particles supporting at least one of silver and zinc are not particularly limited, and include, for example, aluminosilicate (zeolite, etc.), silica gel, silicate glass, phosphate glass (calcium phosphate, zirconium phosphate, etc.), Examples include magnesium aluminate metasilicate, clay minerals, and ceramics. Examples of clay minerals include kaolin, montmorillonite, and talc.
  • the inorganic particles supporting at least one of silver and zinc may be used alone or in combination of two or more.
  • Specific inorganic particles can be obtained by supporting silver ions, zinc ions, etc. on inorganic particles supporting at least one of silver and zinc through an ion exchange reaction.
  • the specific inorganic particles contain one or more compounds selected from the group consisting of silicon-containing compounds and zirconium-containing compounds from the viewpoint of antibacterial properties, ability to support metal components, and the like.
  • the silicon-containing compound is not particularly limited as long as it contains silicon element, and examples thereof include aluminosilicate (such as zeolite), silica gel, silicate glass, and magnesium aluminate metasilicate.
  • the silicon-containing compound preferably contains zeolite, and the specific inorganic particles are preferably silver-supported zeolite, zinc-supported zeolite, silver/zinc-supported zeolite, or the like.
  • Examples of silicon-containing compounds contained in zeolite include silicon dioxide and aluminosilicate.
  • the zeolite may be a natural zeolite or a synthetic zeolite. Specific examples of the zeolite include A-type zeolite, .
  • the zeolite may be, for example, a compound represented by the following formula (1).
  • M is an element such as silver or sodium
  • X, Y and Z are the molar ratios of each component
  • n is the valence of M.
  • the zirconium-containing compound is not particularly limited as long as it contains the zirconium element, and examples thereof include zirconium phosphate, zirconium dioxide, and the like.
  • the inorganic particles supporting at least one of silver and zinc may contain phosphorus compounds such as zirconium phosphate, phosphorus oxide, and calcium phosphate.
  • the phosphorus compound is preferably phosphate glass.
  • the inorganic particles contain a zirconium-containing compound (particularly, contain zirconium phosphate).
  • the specific inorganic particles include a zirconium-containing compound
  • the specific inorganic particles may include a silver-supported zirconium compound, a zinc-supported zirconium compound, or a silver/zinc-supported zirconium compound.
  • the specific inorganic particles contain one or more compounds selected from the group consisting of aluminosilicate and phosphate glass from the viewpoint of antibacterial properties, ability to support metal components, etc.
  • Certain inorganic particles have excellent antibacterial properties and suppress discoloration caused by sulfur components.
  • the content of specific inorganic particles increases, physical property values such as bending strength may decrease, and if the content of specific inorganic particles decreases, discoloration may be suppressed. It can be more effective. From these viewpoints, it is preferable that the content of specific inorganic particles is small, while on the other hand, in order to exhibit antibacterial properties, it is preferable that the content of specific inorganic particles is large. That is, if specific inorganic particles can exhibit antibacterial properties with a smaller amount, it is possible to enhance the effect of suppressing discoloration and suppress a decrease in physical property values such as bending strength. From this point of view, the specific inorganic particles in the present disclosure are preferably aluminosilicates (such as zeolites).
  • the amount of silver, the amount of zinc, or the total amount of silver and zinc in a specific inorganic particle may be independently, for example, from 0.1% by mass to 5.0% by mass, and from 0.5% by mass to 2% by mass. It may be .5% by mass.
  • the volume average particle diameter (D50) of the specific inorganic particles may be, for example, 0.1 ⁇ m to 20 ⁇ m, 0.5 ⁇ m to 15 ⁇ m, 1.0 ⁇ m to 12 ⁇ m, 3 It may be .0 ⁇ m to 12 ⁇ m.
  • the volume average particle diameter (D50) of a specific inorganic particle can be measured using a laser diffraction/scattering particle size distribution analyzer.
  • the content of the specific inorganic particles is preferably 0.01% by mass to 15% by mass based on the total amount of the dental material composition, from the viewpoint of antibacterial properties and the prevention of excessive use of the specific inorganic particles. It is preferably 0.1% by mass to 15% by mass, even more preferably 0.5% by mass to 10% by mass, and particularly preferably 1% by mass to 8% by mass.
  • the content of the specific inorganic particles should be 0.01 parts by mass to 40 parts by mass based on 100 parts by mass of the (meth)acrylate compound, from the viewpoint of antibacterial properties and the prevention of excessive use of the specific inorganic particles. is preferably 0.01 parts by mass to 30 parts by mass, more preferably 0.1 parts by mass to 20 parts by mass, and particularly preferably 0.5 parts by mass to 15 parts by mass. .
  • the dental material composition of the present disclosure includes a (meth)acrylate compound.
  • a (meth)acrylate compound is a compound that contains at least one (meth)acryloyl group and undergoes a radical polymerization reaction with a polymerization initiator to form a polymer.
  • the (meth)acrylate compounds may be used alone or in combination of two or more.
  • the number of (meth)acryloyl groups contained in the (meth)acrylate compound may be one or two or more.
  • the number of (meth)acryloyl groups is preferably 2 or more and 10 or less, more preferably 2 or more and 6 or less, and even more preferably 2 or more and 4 or less.
  • Examples of (meth)acrylate compounds include monofunctional (meth)acrylate compounds containing only one (meth)acryloyl group and polyfunctional (meth)acrylate compounds containing two or more (meth)acryloyl groups.
  • Examples of monofunctional (meth)acrylate compounds include 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 1,3-dihydroxypropyl (meth)acrylate, Examples include 2,3-dihydroxypropyl (meth)acrylate.
  • bifunctional (meth)acrylate compounds containing two (meth)acryloyl groups include: 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-(meth)acryloyloxy)-2-hydroxypropoxyphenyl]propane, 2,2-bis(4-( Aromatic aromas such as meth)acryloyloxyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolypropoxyphenyl)propane, etc.
  • Difunctional (meth)acrylate compounds based on group compounds; Erythritol di(meth)acrylate, sorbitol di(meth)acrylate, mannitol di(meth)acrylate, pentaerythritol di(meth)acrylate, dipentaerythritol di(meth)acrylate, glycerol di(meth)acrylate, ethylene glycol di(meth)acrylate ) acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate Acrylate, 1,3-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)
  • tri- or higher-functional (meth)acrylate compounds containing three or more (meth)acryloyl groups include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, Trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol tri(meth)acrylate, dipentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate Acrylate, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetramethacrylate, 1,7-diacryloyloxy-2,2,6, Examples include 6-tetraacryloyloxymethyl-4-
  • the (meth)acrylate compound preferably contains a (meth)acrylate compound containing two or more (meth)acryloyl groups, an aromatic hydrocarbon group (for example, a phenylene group) or a urethane bond, and two or more (meth)acryloyl groups.
  • an aromatic hydrocarbon group for example, a phenylene group
  • a urethane bond two or more (meth)acryloyl groups.
  • an aromatic hydrocarbon group for example, a phenylene group
  • urethane bond two or more (meth)acryloyl groups.
  • the (meth)acrylate compound may or may not contain an acidic (meth)acrylate compound.
  • an acidic (meth)acrylate compound In the dental material composition of the present disclosure, since specific inorganic particles are used as the antibacterial component, the reaction between the acidic group-containing monomer and the antibacterial component is suitably suppressed.
  • acidic (meth)acrylate compounds include compounds containing an acidic group such as a phosphoric acid group, a pyrophosphoric acid group, a thiophosphoric acid group, a phosphonic acid group, a sulfonic acid group, a carboxylic acid group, and a (meth)acryloyl group. It will be done.
  • the acidic group-containing monomers include 10-(meth)acryloyloxydecyl dihydrogen phosphate (MDP), 1,3-di(meth)acryloyloxypropyl dihydrogen phosphate, and 2- (meth)acryloyloxyethyl dihydrogen phosphate, 4-(meth)acryloyloxyethyl trimellitate anhydride, 4-(meth)acryloyloxyethyl trimellitate, 2-(meth)acrylamido-2-methylpropanesulfonic acid , 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, and dihydroxyethyl methacrylate trimethylhexyl dicarbamate are preferred.
  • MDP 10-(meth)acryloyloxydecyl dihydrogen phosphate
  • 1,3-di(meth)acryloyloxypropyl dihydrogen phosphate 1,3-di(meth)acryloyloxypropy
  • the content of the (meth)acrylate compound may be 10% by mass to 90% by mass, 30% by mass to 80% by mass, or 50% by mass, based on the total amount of the dental material composition. It may be up to 70% by mass.
  • the content of the aromatic ring or urethane bond-containing compound may be 30 parts by mass to 100 parts by mass, or 50 parts by mass to 95 parts by mass, based on 100 parts by mass of the (meth)acrylate compound.
  • the amount may be 70 parts by mass to 90 parts by mass.
  • the (meth)acrylate compound of the present disclosure is preferably liquid at room temperature (for example, 25°C).
  • the dental material composition of the present disclosure includes a polymerization initiator.
  • the polymerization initiator can be a general polymerization initiator used in the dental field, and is usually selected in consideration of the polymerizability and polymerization conditions of the (meth)acrylate compound contained in the composition for dental materials. Ru.
  • a redox-based polymerization initiator for example, a redox-based polymerization initiator that is a combination of an oxidizing agent and a reducing agent is preferable.
  • the oxidizing agent and reducing agent may be packaged separately, and the two may be mixed immediately before use.
  • polymerization initiators examples include organic peroxides such as diacyl peroxides such as benzoyl peroxide and decanoyl peroxide/aromatic amines, cumene hydroperoxide/thiourea, ascorbic acid/copper salts, and organic A redox polymerization initiator such as a peroxide/amine compound/sulfinic acid (or salt thereof) type can be used.
  • organic peroxides such as diacyl peroxides such as benzoyl peroxide and decanoyl peroxide/aromatic amines, cumene hydroperoxide/thiourea, ascorbic acid/copper salts
  • organic A redox polymerization initiator such as a peroxide/amine compound/sulfinic acid (or salt thereof) type can be used.
  • trialkylboranes such as tributylborane and its partial oxides, 5-butylbarbituric acid, 5-butyl-2-thiobarbituri
  • polymerization initiators such as peroxides and azo compounds are preferred.
  • the peroxide is not particularly limited, and examples thereof include benzoyl peroxide, t-butyl hydroperoxide, cumene hydroperoxide, and the like.
  • the azo compound is not particularly limited and includes, for example, azobisisobutyronitrile.
  • ⁇ -diketones such as camphorquinone and acetylbenzoyl
  • benzoyl alkyl ethers such as benzoylethyl ether
  • thioxanthone derivatives such as 2-chlorothioxanthone and methylthioxanthone
  • benzophenone, p, p' Examples include photopolymerization catalysts such as benzophenone derivatives such as -methoxybenzophenone; acylphosphine oxides such as 2,4,6-trimethylbenzoyldiphenylphosphine oxide and 2,6-dimethoxybenzoyldiphenylphosphine oxide.
  • amine compounds such as dimethylaminoethyl methacrylate, N,N-dimethyl-p-toluidine, ethyl p-dimethylaminobenzoate, 2-butoxyethyl 4-(dimethylamino)benzoate
  • co-catalyst components such as aldehyde compounds such as citronellal and dimethylaminobenzaldehyde, and compounds having a thiol group such as 2-mercaptobenzoxazole and decanethiol.
  • aldehyde compounds such as citronellal and dimethylaminobenzaldehyde
  • compounds having a thiol group such as 2-mercaptobenzoxazole and decanethiol.
  • the above polymerization initiators may be used alone or in combination of two or more.
  • the content of the polymerization initiator may be 0.01% by mass to 5% by mass, 0.03% by mass to 1% by mass, or 0.01% by mass to 5% by mass, based on the total amount of the dental material composition. It may be from .05% by weight to 0.5% by weight.
  • the dental material composition of the present disclosure may or may not contain fillers other than the specific inorganic particles described above.
  • the filler other than the specific inorganic particles general fillers used in the dental field can be used.
  • Fillers other than specific inorganic particles are generally classified into organic fillers and inorganic fillers. Fillers other than the specific inorganic particles used in the present disclosure are preferably inorganic fillers.
  • organic filler examples include polymethyl methacrylate, polyethyl methacrylate, methyl methacrylate-ethyl methacrylate copolymer, crosslinked polymethyl methacrylate, crosslinked polyethyl methacrylate, ethylene-vinyl acetate copolymer, and Examples include fine powder such as styrene-butadiene copolymer.
  • Inorganic fillers include, for example, various glasses (mainly containing silicon dioxide, containing heavy metals, oxides such as boron and aluminum as necessary), various ceramics, diatomaceous earth, kaolin, clay minerals (montmorillonite, etc.) , activated clay, synthetic zeolite, mica, calcium fluoride, ytterbium fluoride, calcium phosphate, barium sulfate, zirconium dioxide, titanium dioxide, hydroxyapatite, and other fine powders.
  • inorganic fillers include barium borosilicate glass such as barium boroaluminosilicate glass (Kimbleraysorb T3000, Schott 8235, Schott GM27884 and Schott GM39923, IS 50 1103 Dental Glass (manufactured by FERRO), etc.
  • barium borosilicate glass such as barium boroaluminosilicate glass (Kimbleraysorb T3000, Schott 8235, Schott GM27884 and Schott GM39923, IS 50 1103 Dental Glass (manufactured by FERRO), etc.
  • strontium boroaluminosilicate glasses such as Raysorb T4000, Schott G018-093 and Schott GM32087
  • lanthanum glasses such as Schott GM31684
  • fluoroaluminosilicate glasses such as Schott G018-091 and Schott G018-117
  • zirconium and/or Examples include boroaluminosilicate glasses containing cesium (such as Schott G018-307, G018-308 and G018-310).
  • barium borosilicate glass and strontium boroaluminosilicate glass are preferred as the inorganic filler.
  • an organic-inorganic composite filler obtained by adding a polymerizable compound to these inorganic fillers in advance, making it into a paste, polymerizing and curing it, and pulverizing it.
  • a composition containing microfiller having a particle size of 0.1 ⁇ m or less is one of the preferred embodiments for dental composite resin.
  • Preferable materials for the filler having such a small particle size include silica (eg, Aerosil (trade name)), alumina, zirconia, titania, and the like. Blending such an inorganic filler with a small particle size is advantageous in obtaining polishing smoothness of the cured composite resin.
  • the content of the filler may be 50% by mass or less, and 5% by mass or less based on the total amount of the dental material composition. % to 50% by weight, 10% to 45% by weight, and 20% to 40% by weight.
  • the content of the filler is 50% by mass or less based on the total content of fillers contained in the composition for dental materials. It may be 5% by mass to 50% by mass, 10% by mass to 45% by mass, or 20% by mass to 40% by mass.
  • the total content of fillers means the total content of specific inorganic particles and fillers other than specific inorganic particles.
  • the dental material composition of the present disclosure may contain components other than the above-mentioned components as appropriate depending on the purpose.
  • it may contain a polymerization inhibitor to improve storage stability.
  • known pigments such as pigments and dyes may be included.
  • a known reinforcing material such as fiber may be included.
  • the dental material composition of the present disclosure may or may not contain antibacterial components other than the specific inorganic particles.
  • the content of antibacterial components other than specific inorganic particles may be 5% by mass or less, 3% by mass or less, 1% by mass or less based on the total amount of the dental material composition. It may be 0% by mass.
  • the dental material composition of the present disclosure is preferably liquid at room temperature (for example, 25° C.).
  • the dental material composition of the present disclosure preferably has a viscosity (hereinafter also simply referred to as "viscosity") of 10 mPa ⁇ s to 1,000,000 mPa ⁇ s as measured by an E-type viscometer at 25° C. and 50 rpm. .
  • rpm means revolutions per minute.
  • the viscosity is 10 mPa ⁇ s to 6000 mPa ⁇ s, Excellent handling properties for dental material compositions.
  • the viscosity of the dental material composition of the present disclosure is more preferably from 10 mPa ⁇ s to 6000 mPa ⁇ s, and more preferably from 20 mPa ⁇ s to 5000 mPa ⁇ s. is more preferable, and particularly preferably 100 mPa ⁇ s to 3000 mPa ⁇ s.
  • the viscosity of the composition for dental materials of the present disclosure is 1000 mPa ⁇ s to 1000000 mPa ⁇ s from the viewpoint of improving the handling properties as a dental restorative material. It is more preferably 2000 mPa ⁇ s to 500000 mPa ⁇ s, and particularly preferably 5000 mPa ⁇ s to 300000 mPa ⁇ s.
  • the dental material composition of the present disclosure is preferably used for stereolithography or dental restorative materials.
  • the dental material composition of the present disclosure can be suitably used in a modeling method using a 3D printer.
  • stereolithography is one type of three-dimensional modeling method using a 3D printer.
  • the stereolithography may be inkjet stereolithography or liquid bath stereolithography (that is, stereolithography using a liquid bath).
  • the stereolithography may be a liquid bath type stereolithography.
  • liquid bath type stereolithography examples include DLP (Digital Light Processing) type stereolithography, LCD (Liquid Crystal Display) type stereolithography, and SLA (Stereolithography) type stereolithography.
  • DLP Digital Light Processing
  • LCD Liquid Crystal Display
  • SLA Stepolithography
  • the dental material composition of the present disclosure may be used for dental treatment.
  • the dental treatment method of the present disclosure may include a step of polymerizing the dental material composition of the present disclosure in the oral cavity to obtain a cured product.
  • the method including the step of polymerizing in the oral cavity to obtain a cured product is suitable, for example, when the composition for dental materials is used for dental adhesive resin cement, composite resin for filling and restoration, and the like.
  • the dental treatment method of the present disclosure may include a step of polymerizing the dental material composition of the present disclosure outside the oral cavity to obtain a cured product, and a step of applying the cured product into the oral cavity.
  • the step of polymerizing outside the oral cavity to obtain a cured product may be a step of polymerizing the dental material composition in a cast mold to obtain a cured product, or polymerizing by stereolithography to obtain a cured product. It may be a process.
  • the cured product obtained outside the oral cavity may be processed as necessary, and the cured product after processing may be applied inside the oral cavity.
  • the method of obtaining a cured product by polymerizing outside the oral cavity is suitable, for example, when the cured product is used for CAD/CAM resin blocks, temporary crowns, artificial teeth, etc.
  • the dental material of the present disclosure includes a cured product of the dental material composition of the present disclosure.
  • the dental material of the present disclosure preferably includes a cured product obtained by stereolithography (i.e., a stereolithography product).
  • the dental material of the present disclosure has excellent antibacterial properties, and discoloration due to sulfur components is suppressed.
  • composition for dental materials of the present disclosure and the dental materials of the present disclosure include dental restorative materials, denture base resins, denture base lining materials, impression materials, bonding materials (resin cement, resin-added glass ionomer cement, etc.). ), dental adhesives (orthodontic adhesives, cavity coating adhesives, etc.), tooth fissure sealants, resin blocks for CAD/CAM, temporary crowns, artificial tooth materials, prosthetics, used in the oral cavity Examples include medical instruments and models (Zingiba mask, etc.).
  • dental restorative materials include composite resins for dental crowns, composite resins for filling carious cavities, composite resins for building abutments, and composite resins for filling restorations.
  • prosthetics include complete dentures, partial dentures, and the like.
  • Appliances used in the oral cavity include sports mouthpieces, mouthguards, orthodontic mouthpieces, splints such as occlusal adjustment splints or temporomandibular joint disorder treatment splints, and splints used to treat sleep apnea syndrome. Examples include mouthpieces.
  • UDMA 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl) dimethacrylate
  • 3G Triethylene glycol dimethacrylate
  • CQ Camphorquinone DMBE: 2-Butoxyethyl 4-(dimethylamino)benzoate
  • Luperox Luperox 531M80 (Arkema Yoshitomi Co., Ltd.)
  • Ag Silver powder
  • Silver-supported zeolite Aluminosilicate, manufactured by Sinanen Zeomic Co., Ltd., D50: 5.5 ⁇ m to 10 ⁇ m
  • Silver-supported phosphate glass manufactured by Sinanen Zeomic Co., Ltd., D50: 8.0 ⁇ m to 12 ⁇ m
  • a 25 ⁇ m thick PET film was placed on the glass, and a 1 mm thick silicone mold was placed on top of it.
  • the prepared composition was placed in the mold, another PET film was placed on the composition, and then another glass was covered from above. After that, the two pieces of glass were pressed together, and using Alphalight V LCR11 (manufactured by Morita Co., Ltd.), light was irradiated on the front and back sides for 3 minutes each to completely cure them, and Examples 1 to 4 and Test pieces for antibacterial evaluation of Comparative Examples 1 and 2 were prepared.
  • a test piece for antibacterial evaluation (a test piece serving as a standard for antibacterial evaluation) of Comparative Example 3 was prepared in the same manner as in Example 1, except that no inorganic material was used.
  • Antibacterial evaluation 1 (thermal cycle not performed)
  • a test piece for antibacterial evaluation (3.5 cm long, 3.5 cm wide, and 1 mm thick) was ultrasonically cleaned in ethanol for 10 minutes, and then the ethanol was replaced with ultrapure water and the ultrasonic cleaning was performed again for 10 minutes. The remaining (meth)acrylate compound was removed.
  • the antibacterial evaluation test piece was subjected to an antibacterial test against Streptococcus mutans NBRC13955 (distributed by the Biotechnology Center of the National Institute of Technology and Evaluation) according to the method described in JIS Z 2801:2012. was carried out as follows, and the antibacterial activity value was calculated.
  • test pieces were disinfected with an 80% by mass ethanol aqueous solution and thoroughly dried.
  • Streptococcus mutans was cultured overnight in Brain Heart Infusion Medium (Nippon Becton Dickinson Model No. 237500), and the number of bacteria was adjusted to 2.5 x 10 5 cells/mL to 10 x 10 5 cells/mL in the same medium.
  • a sterilized PET film (3 cm long, 3 cm wide, and 25 ⁇ m thick) was placed and brought into close contact.
  • This test piece was cultured at 37°C for 24 hours under microaerobic conditions (specifically, oxygen concentration 6% by volume) using an anaerobic/microaerobic culture jar system Anoxomat Mark II (Central Kagaku Boeki Co., Ltd.). went. Thereafter, the culture solution was collected and diluted using phosphate buffered saline, seeded on a brain heart infusion agar medium, and cultured at 37° C. for 48 hours under microaerobic conditions, and the number of viable bacteria was measured.
  • the formula for calculating the antibacterial activity value R is as follows.
  • Comparative Example 3 in Table 1 was treated as an unprocessed test piece.
  • Antibacterial activity value U0: Average value of the logarithm of the number of viable bacteria immediately after inoculation of the untreated test piece
  • Ut Average value of the logarithm of the number of viable bacteria 24 hours after inoculation of the untreated test piece
  • the antibacterial activity value R is an index of antibacterial properties; the larger the value, the higher the antibacterial activity, and a value of 2.0 or more is judged to have antibacterial activity. The results are shown in Table 1.
  • Example 4 The prepared composition was placed in the mold, and another sheet of glass was placed over the composition. Thereafter, the two pieces of glass were pressed together and heated in an oven at 100° C. for one hour to completely cure the glass to prepare test pieces for antibacterial evaluation of Examples 5 to 8 and Comparative Example 4.
  • a test piece for antibacterial evaluation of Comparative Example 4 was prepared in the same manner as in Example 5, except that no inorganic material was used.
  • Antibacterial evaluation 1 (thermal cycle not performed) and hue change test were conducted in the same manner as in Example 1. The results are shown in Table 2.

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Dental Preparations (AREA)

Abstract

L'invention concerne une composition pour un matériau dentaire contenant des particules inorganiques supportant au moins un constituant métallique choisi dans le groupe constitué par l'argent et le zinc, un composé (méth)acrylate et un initiateur de polymérisation.
PCT/JP2023/010757 2022-03-24 2023-03-17 Composition pour matériau dentaire et matériau dentaire WO2023182241A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2022-048776 2022-03-24
JP2022048776 2022-03-24
JP2022204889 2022-12-21
JP2022-204889 2022-12-21

Publications (1)

Publication Number Publication Date
WO2023182241A1 true WO2023182241A1 (fr) 2023-09-28

Family

ID=88100888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2023/010757 WO2023182241A1 (fr) 2022-03-24 2023-03-17 Composition pour matériau dentaire et matériau dentaire

Country Status (1)

Country Link
WO (1) WO2023182241A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10147503A (ja) * 1996-11-16 1998-06-02 Shiken:Kk 歯科材料組成物
US20050265931A1 (en) * 2002-06-21 2005-12-01 Kerr Corporation Silver-containing dental composition
WO2019117206A1 (fr) * 2017-12-13 2019-06-20 クラレノリタケデンタル株式会社 Composition dentaire contenant des nanoparticules de platine
CN112353694A (zh) * 2020-11-06 2021-02-12 无锡市腰果新材料有限公司 一种可用于临床牙科临时冠的dlp型3d打印光固化材料
WO2021033585A1 (fr) * 2019-08-20 2021-02-25 三井化学株式会社 Procédé de production de composition de monomère, composition de matériau, composition de monomère, composition durcissable, et article moulé

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10147503A (ja) * 1996-11-16 1998-06-02 Shiken:Kk 歯科材料組成物
US20050265931A1 (en) * 2002-06-21 2005-12-01 Kerr Corporation Silver-containing dental composition
WO2019117206A1 (fr) * 2017-12-13 2019-06-20 クラレノリタケデンタル株式会社 Composition dentaire contenant des nanoparticules de platine
WO2021033585A1 (fr) * 2019-08-20 2021-02-25 三井化学株式会社 Procédé de production de composition de monomère, composition de matériau, composition de monomère, composition durcissable, et article moulé
CN112353694A (zh) * 2020-11-06 2021-02-12 无锡市腰果新材料有限公司 一种可用于临床牙科临时冠的dlp型3d打印光固化材料

Similar Documents

Publication Publication Date Title
US7488762B2 (en) Two paste-type glass ionomer cement
CA2814863C (fr) Substance dentaire a haute resistance mecanique
US9452112B2 (en) Dental compositions
US7470728B2 (en) Dental glazes and method of manufacture and use thereof
EP1787623B1 (fr) Composition dentaire polymérisable
WO2001090251A1 (fr) Composition antimicrobienne
JPH08231330A (ja) 重合性歯科材料
Fink Materials, chemicals and methods for dental applications
US11311357B2 (en) Dental composite material and mill blanks consisting of said composite material
JP2013189482A (ja) シーラント用のナノメートルサイズのシリカ粒子を含む歯科用組成物
AlSahafi et al. Novel antibacterial low-shrinkage-stress resin-based cement
JP3449770B2 (ja) 抗菌性歯科用組成物
JP2002114620A (ja) 歯科充填用ガラスおよびそのガラス粒子を含む歯科用組成物
WO2023182241A1 (fr) Composition pour matériau dentaire et matériau dentaire
KR101009745B1 (ko) 항균력을 갖는 치과용 시멘트 조성물
JP3296445B2 (ja) 抗菌性組成物
JP4334860B2 (ja) 抗菌性歯科用重合性組成物
JPH0791171B2 (ja) 矯正用光硬化型樹脂複合組成物
JP2021054795A (ja) 低感水性歯科用組成物
JP2019163247A (ja) 連鎖移動剤を含む歯科用接着性組成物
KR102668433B1 (ko) 고강도 및 고심미성의 치아 수복용 강화 복합소재 및 그 제조방법
JP7261555B2 (ja) 接着性を向上させた歯科切削用レジン硬化体
JP2010202560A (ja) 歯科用複合硬化性組成物
JP4636586B2 (ja) 歯科材料用プライマー
Filemban Novel Bioactive Low-Shrinkage-Stress Nanocomposite with Antibacterial and Remineralization Properties and Thermal-Cycling and Aging Resistance

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23774836

Country of ref document: EP

Kind code of ref document: A1